Roivant

Roivant spinout ends development of lung disease asset after phase 2 fail
Fierce Biotech
Tue, 12/3/24 - 11:15 am
Kinevant
Roivant
monoclonal antibodies
namilumab
Roivant’s magic trick: Finding the ‘weird-shaped’ pieces around Big Pharma’s cookie cutters
Pharma Voice
Thu, 09/26/24 - 11:00 am
Roivant
Dermavant
Organon
M&A
Big Pharma
Matt Gline
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Fierce Pharma
Wed, 09/18/24 - 01:39 pm
Organon
Roivant
Dermavant
M&A
immuno-dermatology
Roivant reveals positive immune drug data, share buyback plans
BioPharma Dive
Tue, 04/2/24 - 10:01 pm
Roivant
clinical trials
uveitis
Pfizer
brepocitinib
non-infectious uveitis
Roivant to Shutter MDS-Focused ‘Vant’ After Disappointing Phase I/II Trial Results
BioSpace
Wed, 02/14/24 - 10:57 am
Roivant
TVT-2001
MDS
Hemavant
BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues
Fierce Biotech
Tue, 02/13/24 - 11:31 am
Bristol Myers Squibb
Roivant
VantAI
artificial intelligence
molecular glue
Immunovant stakes claim for FcRn niche, posting midphase Graves’ data and plotting next steps
Fierce Biotech
Thu, 12/21/23 - 09:46 am
Immunovant
anti-FcRn
clinical trials
Graves' disease
Roivant
Roivant ends longshot lupus program after phase 2 fail
Fierce Biotech
Tue, 11/28/23 - 10:32 am
Roivant
lupus
clinical trials
brepocitnib
Roivant’s $7B Roche deal was a ‘moment of opportunity,’ CEO says
BioPharma Dive
Tue, 10/31/23 - 09:32 pm
Roivant
Televant
M&A
Roche
Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race
Fierce Biotech
Wed, 10/4/23 - 09:48 am
Sanofi
Teva Pharmaceutical
inflammatory bowl disease
IBD
Merck
Roivant
Immunovant shares surge as early antibody treatment data beats expectations
Yahoo/Reuters
Tue, 09/26/23 - 11:43 am
Roivant
Immunovant
antibodies
clinical trials
IMVT-1402
autoimmune diseases
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Thu, 08/24/23 - 10:25 am
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report
BioSpace
Fri, 07/14/23 - 11:56 am
Roche
Roivant
ulcerative colitis
Crohn's Disease
M&A
Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?
Motley Fool
Mon, 04/24/23 - 10:18 am
Pfizer
Roivant
IBD
RVT-3101
Biotech entrepreneur Vivek Ramaswamy launched his 2024 GOP presidential bid
Yahoo Finance
Wed, 02/22/23 - 10:05 am
Vivek Ramaswamy
Roivant
2024 Presidential election
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Pfizer hands another asset to Roivant
EP Vantage
Fri, 12/2/22 - 10:56 am
Pfizer
Roivant
RVT-3101
PF-06480605
Prometheus Biosciences
Roivant Reduces Pipeline by Several Programs Across Vants
BioSpace
Tue, 06/28/22 - 06:05 pm
Roivant

Pages